Literature DB >> 16902368

Community exposure to perfluorooctanoate: relationships between serum concentrations and exposure sources.

Edward Anthony Emmett1, Frances Susan Shofer, Hong Zhang, David Freeman, Chintan Desai, Leslie Michael Shaw.   

Abstract

OBJECTIVE: The objective of this study was to determine serum (perfluorooctanoate [PFOA]) in residents near a fluoropolymer production facility: the contributions from air, water, and occupational exposures, personal and dietary habits, and relationships to age and gender.
METHODS: The authors conducted questionnaire and serum PFOA measurements in a stratified random sample and volunteers residing in locations with the same residential water supply but with higher and lower potential air PFOA exposure.
RESULTS: Serum (PFOA) greatly exceeded general population medians. Occupational exposure from production processes using PFOA and residential water had additive effects; no other occupations contributed. Serum (PFOA) depended on the source of residential drinking water, and not potential air exposure. For public water users, the best-fit model included age, tap water drinks per day, servings of home-grown fruit and vegetables, and carbon filter use.
CONCLUSIONS: Residential water source was the primary determinant of serum (PFOA).

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16902368      PMCID: PMC3038253          DOI: 10.1097/01.jom.0000232486.07658.74

Source DB:  PubMed          Journal:  J Occup Environ Med        ISSN: 1076-2752            Impact factor:   2.162


  19 in total

Review 1.  Leydig cell hyperplasia and adenoma formation: mechanisms and relevance to humans.

Authors:  E D Clegg; J C Cook; R E Chapin; P M Foster; G P Daston
Journal:  Reprod Toxicol       Date:  1997 Jan-Feb       Impact factor: 3.143

2.  Comparative studies on sex-related difference in biochemical responses of livers to perfluorooctanoic acid between rats and mice.

Authors:  N Uy-Yu; Y Kawashima; H Kozuka
Journal:  Biochem Pharmacol       Date:  1990-05-01       Impact factor: 5.858

3.  Penetration of ammonium perfluorooctanoate through rat and human skin in vitro.

Authors:  W J Fasano; G L Kennedy; B Szostek; D G Farrar; R J Ward; L Haroun; P M Hinderliter
Journal:  Drug Chem Toxicol       Date:  2005       Impact factor: 3.356

4.  Quantitative determination of perfluorooctanoic acid in serum and plasma by liquid chromatography tandem mass spectrometry.

Authors:  John M Flaherty; Paul D Connolly; Emily R Decker; S Mark Kennedy; Mark E Ellefson; William K Reagen; Bogdan Szostek
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2005-05-25       Impact factor: 3.205

5.  The modulation of rat liver carcinogenesis by perfluorooctanoic acid, a peroxisome proliferator.

Authors:  A G Abdellatif; V Préat; H S Taper; M Roberfroid
Journal:  Toxicol Appl Pharmacol       Date:  1991-12       Impact factor: 4.219

6.  Perfluorooctanoate: Placental and lactational transport pharmacokinetics in rats.

Authors:  Paul M Hinderliter; Eve Mylchreest; Shawn A Gannon; John L Butenhoff; Gerald L Kennedy
Journal:  Toxicology       Date:  2005-04-19       Impact factor: 4.221

7.  Mechanisms of extrahepatic tumor induction by peroxisome proliferators in male CD rats.

Authors:  L B Biegel; M E Hurtt; S R Frame; J C O'Connor; J C Cook
Journal:  Toxicol Sci       Date:  2001-03       Impact factor: 4.849

8.  Induction of Leydig cell adenomas by ammonium perfluorooctanoate: a possible endocrine-related mechanism.

Authors:  J C Cook; S M Murray; S R Frame; M E Hurtt
Journal:  Toxicol Appl Pharmacol       Date:  1992-04       Impact factor: 4.219

9.  Exposure assessment and risk characterization for perfluorooctanoate in selected consumer articles.

Authors:  Stephen T Washburn; Timothy S Bingman; Scott K Braithwaite; Robert C Buck; L William Buxton; Harvey J Clewell; Lynne A Haroun; Janet E Kester; Robert W Rickard; Annette M Shipp
Journal:  Environ Sci Technol       Date:  2005-06-01       Impact factor: 9.028

10.  Historical comparison of perfluorooctanesulfonate, perfluorooctanoate, and other fluorochemicals in human blood.

Authors:  Geary W Olsen; Han-Yao Huang; Kathy J Helzlsouer; Kristen J Hansen; John L Butenhoff; Jeffrey H Mandel
Journal:  Environ Health Perspect       Date:  2005-05       Impact factor: 9.031

View more
  80 in total

1.  Perfluorooctanoic Acid (PFOA)-induced Liver Lesions in Two Strains of Mice Following Developmental Exposures: PPARα Is Not Required.

Authors:  Adam J Filgo; Erin M Quist; Mark J Hoenerhoff; Amy E Brix; Grace E Kissling; Suzanne E Fenton
Journal:  Toxicol Pathol       Date:  2014-11-14       Impact factor: 1.902

2.  Variability and predictors of serum perfluoroalkyl substance concentrations during pregnancy and early childhood.

Authors:  Samantha L Kingsley; Melissa N Eliot; Karl T Kelsey; Antonia M Calafat; Shelley Ehrlich; Bruce P Lanphear; Aimin Chen; Joseph M Braun
Journal:  Environ Res       Date:  2018-05-07       Impact factor: 6.498

3.  Per- and Polyfluoroalkyl Substances and Obesity, Type 2 Diabetes and Non-alcoholic Fatty Liver Disease: A Review of Epidemiologic Findings.

Authors:  Weipeng Qi; John M Clark; Alicia R Timme-Laragy; Yeonhwa Park
Journal:  Toxicol Environ Chem       Date:  2020-05-22       Impact factor: 1.437

4.  Serum biomarkers of polyfluoroalkyl compound exposure in young girls in Greater Cincinnati and the San Francisco Bay Area, USA.

Authors:  Susan M Pinney; Frank M Biro; Gayle C Windham; Robert L Herrick; Lusine Yaghjyan; Antonia M Calafat; Paul Succop; Heidi Sucharew; Kathleen M Ball; Kayoko Kato; Lawrence H Kushi; Robert Bornschein
Journal:  Environ Pollut       Date:  2013-10-01       Impact factor: 8.071

5.  Perfluoroalkyl substances and metabolic outcomes in pregnancy.

Authors:  Jørn Olsen; Zeyan Liew
Journal:  J Public Health Emerg       Date:  2018-02-10

6.  Rate of decline in serum PFOA concentrations after granular activated carbon filtration at two public water systems in Ohio and West Virginia.

Authors:  Scott M Bartell; Antonia M Calafat; Christopher Lyu; Kayoko Kato; P Barry Ryan; Kyle Steenland
Journal:  Environ Health Perspect       Date:  2010-02       Impact factor: 9.031

7.  Dietary predictors and plasma concentrations of perfluorinated compounds in a coastal population from northern Norway.

Authors:  Charlotta Rylander; Magritt Brustad; Helena Falk; Torkjel M Sandanger
Journal:  J Environ Public Health       Date:  2010-01-06

Review 8.  Epidemiologic evidence on the health effects of perfluorooctanoic acid (PFOA).

Authors:  Kyle Steenland; Tony Fletcher; David A Savitz
Journal:  Environ Health Perspect       Date:  2010-04-27       Impact factor: 9.031

9.  Development of PBPK models for PFOA and PFOS for human pregnancy and lactation life stages.

Authors:  Anne E Loccisano; Matthew P Longnecker; Jerry L Campbell; Melvin E Andersen; Harvey J Clewell
Journal:  J Toxicol Environ Health A       Date:  2013

10.  Predictors of PFOA levels in a community surrounding a chemical plant.

Authors:  Kyle Steenland; Chuangfang Jin; Jessica MacNeil; Cathy Lally; Alan Ducatman; Veronica Vieira; Tony Fletcher
Journal:  Environ Health Perspect       Date:  2009-03-23       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.